ololand-forensic-qoe-ebitda-bridge — independently scanned and version-tracked by SaferSkills.
SaferSkills independently audited ololand-forensic-qoe-ebitda-bridge (Agent Skill) and scored it 100/100 (green). The audit ran 55 deterministic rules across Security, Supply Chain, Maintenance, Transparency, and Community; it found 0 high-severity and 0 lower-severity findings. The full rule-by-rule trace and per-finding evidence are below. Free, methodology-open.
Findings & checks · 0 flagged
Every scanned point with the score it earned and what moved between them.
First recorded scan — no prior version to compare against.
The primary manifest — the file an agent reads to learn what this artifact does.
<!-- Generated by scripts/generate-plugin-artifacts.py; do not edit. -->
Follow the OloLand command instructions below when the user asks for /ebitda-bridge or the equivalent workflow in Codex.
Walks reported EBITDA to adjusted/normalized EBITDA, classifying every add-back. The classifier flags add-backs that look one-time but recur, pro-forma adjustments that lack supporting documentation, and any management add-back that doesn't survive scrutiny.
/ebitda-bridge <deal_id>deal_id (required) — The deal to analyze. Requires reported EBITDA + management's adjustment schedule + 2-3 years of historical financials for recurrence testing.build_ebitda_bridge(deal_id) from the MCP server. If the user supplied explicit financial data, pass it as financial_data. Do not pass a primitives argument to analyze_forensic_qoe; that tool runs the full deal-scoped battery.| Add-back | Mgmt $ | Classification | Normalized $ | Why |
|---|---|---|---|---|
| Owner comp normalization | 1,200K | accepted | 1,200K | sole-shareholder, replacement comp documented |
| "One-time" legal | 450K | recurring | 0K | also in FY23, FY22, FY21 |
| COVID add-back | 800K | questionable | 400K | Q2'21 only, no supporting invoices for 50% |
Plus a summary line: management EBITDA $X.XM → normalized EBITDA $Y.YM (delta $Z.ZM).
Inflated EBITDA is the #1 driver of overpaying in PE deals. The EBITDA bridge classifier is the single most important forensic test in QoE. Running it pre-LOI tells you whether the headline multiple you're solving for is even directionally right.
/ebitda-bridge deal_acme_2026~30 seconds. Free. No account. Every finding cites a rule and a line of evidence.